glp-1 vs tirzepatide Semaglutide for Weight Loss: Which is Better? Beyond glycemia: Comparing tirzepatide to

doi: 10.2337/dc20-S009 6 ArpaiaN.CampbellC.FanX.DikiyS.van der VeekenJ.deRoosP.et al

Lilly has also taken a vocal stance against the use of obesity medicine for cosmetic weight loss

The five flagship GLP-1 products from these two companiesNovo's Ozempic, Wegovy, and Rybelsus alongside Lilly's Mounjaro and Zepbound have collectively generated over $71 billion in U.S

MACE 4P, 4-point cardiovascular composite episode, including hospitalization due to non-stable angina

Clinical trials showed HbA1c reductions of roughly 1.3% to 1.6%, placing it within the range expected for GLP-1 receptor agonists currently used in diabetes care

The results were extraordinary